Latest News

When close to half the companies in Finland have price-to-earnings ratios (or "P/E's") above 20x, you may consider...

A lackluster earnings announcement from São Martinho S.A. ( BVMF:SMTO3 ) last week didn't sink the stock price. We...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Rentokil Initial fair value estimate is UK£4.27 With UK£4.42...

With a median price-to-earnings (or "P/E") ratio of close to 10x in South Africa, you could be forgiven for feeling...

INDUS Holding AG ( ETR:INH ), might not be a large cap stock, but it led the XTRA gainers with a relatively large price...

Hufvudstaden AB (publ)'s ( STO:HUFV A ) dividend will be increasing from last year's payment of the same period to...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Today is shaping up negative for Blue Jet Healthcare Limited ( NSE:BLUEJET ) shareholders, with the analysts delivering...

As you might know, Hindware Home Innovation Limited ( NSE:HINDWAREAP ) recently reported its third-quarter numbers. The...

The Bombay Burmah Trading Corporation Limited ( NSE:BBTC ) is about to trade ex-dividend in the next three days. The...

In recent days, Ross Stores reported solid quarterly results, with revenue and comparable sales topping cautious expectations, supported by strong customer traffic in apparel and home categories. The company is also pushing ahead with an expansion program underpinned by average same-store sales growth of 3.4% over the past two years and an industry-leading 30.6% return on capital, highlighting management’s focus on high-return store investments. Next, we’ll explore how Ross Stores’ ongoing...

Why Ecovyst stock is back on investors’ radar Ecovyst (ECVT) is drawing fresh attention after Brightline Capital Management disclosed a new position of 2,050,000 shares, along with the company’s plan to sell its Advanced Materials and Catalysts segment for US$556 million. See our latest analysis for Ecovyst. Ecovyst’s recent news sits against a share price that closed at US$11.62, with a 39.66% 90 day share price return and a 41.53% 1 year total shareholder return. This suggests momentum has...

IDT Corporation previously filed a US$10.95 million shelf registration for 175,000 shares of Class B common stock tied to an ESOP-related offering, while a new 1% federal excise tax on certain cash-funded international money transfers took effect on January 1, 2026. Because IDT’s BOSS Money app allows users to fund transfers via debit cards or bank accounts, customers can avoid this new tax, potentially making the service more attractive in a crowded remittance market. We’ll now examine how...

Earlier this month, Bank of Hawai‘i announced that longtime Chairman and CEO Peter S. Ho, age 60, will retire on March 31, 2026, with President and Chief Banking Officer James C. Polk, age 59, set to succeed him under the bank’s long-planned leadership transition, while Ho stays on as consultant through 2027. The move also separates the Chairman and CEO roles, with Raymond P. Vara, Jr. becoming Non-Executive Chairman, underscoring the bank’s focus on continuity, governance and succession...

Earnings event puts Eisai in focus Eisai (TSE:4523) is back in the spotlight after reporting nine month earnings to December 31, 2025, with higher sales but softer net income and earnings per share catching investor attention. See our latest analysis for Eisai. The mixed earnings update and the recent board meeting appear to sit against a backdrop where momentum has picked up in the short term. The 7 day share price return is 9.40% and the 1 year total shareholder return is 18.49%, even...

Earnings event that moved the stock Far East Hospitality Trust (SGX:Q5T) released its full year 2025 results, reporting sales of S$106.05 million and net income of S$33.91 million, both below the previous year, a combination that can quickly shift investor sentiment. See our latest analysis for Far East Hospitality Trust. Following the earnings release, Far East Hospitality Trust’s share price has edged higher, with a 30 day share price return of 1.63% and a 3.31% year to date gain, while the...

Today is shaping up negative for Mandatum Oyj ( HEL:MANTA ) shareholders, with the analysts delivering a substantial...

The Ensign Group reported past fourth-quarter and full-year 2025 results showing higher revenue and earnings, issued 2026 earnings guidance of US$7.41 to US$7.61 per diluted share and revenue guidance of US$5.77 billion to US$5.84 billion, and disclosed no share repurchases under its existing buyback authorization. Alongside this guidance, Ensign expanded its footprint to 378 healthcare operations across 17 states through several skilled nursing facility acquisitions, underscoring...

Analyst optimism and record high share price put Turning Point Brands in focus Turning Point Brands (TPB) has moved into the spotlight after Oppenheimer issued upbeat commentary on the stock, highlighting expectations around the FRE brand, nicotine pouch exposure, and the company’s broader brick and mortar rollout. See our latest analysis for Turning Point Brands. The latest analyst commentary has arrived alongside a strong run in the stock, with a 1 month share price return of 10.78% and 3...

The Pennant Group recently confirmed it released its fourth-quarter and full-year 2025 results on February 25, 2026, followed by a webcast on February 26, 2026, to discuss performance in its home health, hospice, and senior living operations across 17 states. Beyond the formal results date, management’s emphasis on steady home health and hospice growth, disciplined cost control, and selective expansion has been a key focus for investors assessing the business. Now we’ll examine how Pennant’s...

Guardant Health (GH) has been in focus after disclosures that key insiders and a major shareholder reduced their holdings, along with fresh clinical data on its Guardant Reveal test and a new Shield-based colorectal cancer screening grant program. See our latest analysis for Guardant Health. Guardant Health’s recent insider selling and fresh clinical data arrive after a mixed few weeks for the share price. The stock has a 9.71% 90 day share price return and a 117.89% 1 year total shareholder...

Why Fidelity National Financial Is On Investors’ Radar Fidelity National Financial (FNF) is drawing attention after recent share price moves, with the stock closing at US$56.74 and showing mixed returns over the past month and past 3 months. See our latest analysis for Fidelity National Financial. Recent trading has been choppy, with a 7.32% 1 month share price return and a 4.53% year to date share price return, while long term holders are sitting on a 54.12% 3 year total shareholder return...

Ingersoll Rand recently reported its fourth-quarter and full-year 2025 results, showing year-on-year increases in quarterly sales and earnings alongside lower impairment charges and confirming 2026 revenue growth guidance of 2.5% to 4.5%. Despite full-year 2025 net income declining compared with 2024, the company used strong cash generation to fund acquisitions, complete a US$1.77 billion share repurchase program, and maintain its regular dividend. Next, we’ll examine how this strong quarter...